HomeInsightsStock Comparison

Sun Pharmaceutical Industries Ltd vs Wockhardt Ltd Stock Comparison

Sun Pharmaceutical Industries Ltd vs Wockhardt Ltd Stock Comparison

Last Updated on: May 18, 2025

Key Highlights

  • The Latest Trading Price of Sun Pharmaceutical Industries Ltd is ₹ 1734 as of 16 May 15:30.
  • The P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 yearsThe P/E Ratio of Wockhardt Ltd changed from 6.6 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
  • The Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 388812 crore on March 2024 . This represents a CAGR of 35.70% over 5 yearsThe Market Cap of Wockhardt Ltd changed from ₹ 1912 crore on March 2020 to ₹ 8951 crore on March 2024 . This represents a CAGR of 36.16% over 5 years.
  • The revenue of Sun Pharmaceutical Industries Ltd for the Dec '24 is ₹ 14141 crore as compare to the Sep '24 revenue of ₹ 13645 crore. This represent the growth of 3.63% The revenue of Wockhardt Ltd for the Dec '24 is ₹ 729 crore as compare to the Sep '24 revenue of ₹ 818 crore. This represent the decline of -10.88%.
  • The ebitda of Sun Pharmaceutical Industries Ltd for the Dec '24 is ₹ 4158 crore as compare to the Sep '24 ebitda of ₹ 4292 crore. This represent the decline of -3.13% The ebitda of Wockhardt Ltd for the Dec '24 is ₹ 136 crore as compare to the Sep '24 ebitda of ₹ 119 crore. This represent the growth of 14.29%.
  • The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2917 crore over 7 quarters. This represents a CAGR of 23.62% The net profit of Wockhardt Ltd changed from ₹ -136 crore to ₹ 20 crore over 7 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 113.33 % on March 2024 . This represents a CAGR of 30.55% over 5 yearsThe Dividend Payout of Wockhardt Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

About Wockhardt Ltd

  • Wockhardt Limited, incorporated in July, 1999 is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world.
  • The Company is India's leading research-based global healthcare enterprise in fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.
  • It has 12 manufacturing locations and there are 3 locations where research and development activities are carried out. The Company has manufacturing and research facilities in India, USA & UK and a manufacturing facility in Ireland.
  • It has a significant presence in USA, Europe and India, with 83% of its global revenues coming from international businesses.
  • Wockhardt is the only company in the world where USFDA has given QIDP Status (Qualified lnfectious Diseases Programme) for 5 of Anti-bacterial discovery programmes - 2 of them are Gram Negative and 3 Gram Positive effective against untreatable 'Superbugs'.

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharmaceutical Industries Ltd Spurts 2.83%, BSE Healthcare index Rises 1.26%

Sun Pharmaceutical Industries Ltd rose 2.83% today to trade at Rs 1733.95. The BSE Healthc...

Read more

13 May 2025 09:30

News

Sun Pharmaceutical Industries Ltd Slips 5.32%

Sun Pharmaceutical Industries Ltd fell 5.32% today to trade at Rs 1652.1. The BSE Healthca...

Read more

12 May 2025 09:30

News

Sun Pharmaceutical Industries Ltd eases for fifth straight session

Sun Pharmaceutical Industries Ltd dropped for a fifth straight session today. The stock is...

Read more

12 May 2025 13:35

News

Sun Pharmaceuticals Industries announces board meeting date

Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...

Read more

12 May 2025 15:56

News

Sun Pharma and Israel-based Moebius Medical publish two articles on MM-II

Sun Pharmaceutical Industries and Israel-based Moebius Medical announced today the publica...

Read more

24 Apr 2025 09:12

News

Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India

Sun Pharmaceutical Industries has launched Fexuprazan tablets 40 mg in India under the bra...

Read more

07 Apr 2025 09:07

Wockhardt Ltd News Hub

News

Wockhardt announces incorporation of step-down subsidiary in Ireland

Wockhardt Bio AG, a subsidiary of Wockhardt, has incorporated a new Wholly Owned Subsidiar...

Read more

08 Apr 2025 19:55

News

Wockhardt surges after breakthrough US cancer treatment with Zaynich

The 15-year-old patient, diagnosed with Acute Myeloid Leukemia (AML), had been battling a ...

Read more

01 Apr 2025 11:32

News

Wockhardt announces board meeting date

Wockhardt will hold a meeting of the Board of Directors of the Company on 7 February 2025....

Read more

03 Feb 2025 16:52

News

Wockhardt spurts after Indian drug regulator approves Pneumonia antibiotic

Miqnaf is an ultra-short course, once-a-day, 3-day treatment for CABP, including those cau...

Read more

03 Jan 2025 11:22

News

Wockhardt to conduct board meeting

Wockhardt will hold a meeting of the Board of Directors of the Company on 13 November 2024...

Read more

08 Nov 2024 16:42

News

Wockhardt slumps on launching QIP at discount

The floor price indicates a steep discount of 8.5% over the stock's closing price on Wedne...

Read more

07 Nov 2024 14:38

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Wockhardt Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Wockhardt Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Sun Pharmaceutical Industries Ltd and Wockhardt Ltd

Which company has a larger market capitalization, Sun Pharmaceutical Industries Ltd or Wockhardt Ltd?

Market cap of Sun Pharmaceutical Industries Ltd is 416,272 Cr while Market cap of Wockhardt Ltd is 21,597 Cr

What are the key factors driving the stock performance of Sun Pharmaceutical Industries Ltd and Wockhardt Ltd?

The stock performance of Sun Pharmaceutical Industries Ltd and Wockhardt Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharmaceutical Industries Ltd and Wockhardt Ltd?

As of May 18, 2025, the Sun Pharmaceutical Industries Ltd stock price is INR ₹1734.95. On the other hand, Wockhardt Ltd stock price is INR ₹1329.2.

How do dividend payouts of Sun Pharmaceutical Industries Ltd and Wockhardt Ltd compare?

To compare the dividend payouts of Sun Pharmaceutical Industries Ltd and Wockhardt Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions